Italy: OMX Groupe enters Italian market with acquisition of Next Medical
France-based OMX Groupe, a medical technology distribution group. has completed the acquisition of Next Medical, an Italy-based distributor of medical devices in the fields...
Germany/Netherlands: Arcura completes over 14,000 sqm of lease deals
Arcura Medical Properties, a European healthcare real estate platform focused on medical outpatient buildings and clinical infrastructure, has secured over 14,000 sqm of lease...
France: Riverside invests in Medical Group and forms strategic partnership with Selenium Medical
The Riverside Company, a US-based global investment firm focused on the smaller end of the middle market, has invested in Medical Group, a French...
UK: British Business Bank to commit up to £135m to two new Advent Life...
The British Business Bank, the UK government’s economic development bank, has agreed to commit £60m to Advent Life Sciences Fund IV and committed £75m...
France: Sofinnova Partners closes oversubscribed €82m MD Start IV fund
Sofinnova Partners, a France-based European life sciences venture capital firm, has announced the final close of Sofinnova MD Start IV at €82m (US$93m). The...
Germany: Bridgepoint takes majority shareholding in Altano Group from Ufenau
UK‑listed Bridgepoint, a global mid‑market investor, is to acquire a majority shareholding in Altano Group, the world's largest group of equine clinics and practice, from...
Belgium: Gimv completes €150m private placement bond
Brussels-listed Gimv has completed a €150m (US$171m) 5.532% eight-year private placement bond issue via arranger and sole bookrunner KBC Securities. Bonds were placed with...
UK: Duke Street sells Kent-Athlone Pharma Group to Phoenix Labs
European mid-market investor, Duke Street, has sold specialty pharma group, Kent Pharmaceuticals, to Phoenix Labs, an integrated healthcare company operating in the prescription and...
Europe’s opportunity to capture the value in China biotech. McDermott Will & Schulte’s Emmanuelle...
China is no longer simply a low-cost engine for biotech development but an increasingly important source of innovation. For European companies and investors, that...
Spain: Buenavista appoints Enrique Centelles Satrústegui as its new CEO
Buenavista Equity Partners, an independent investment management firm specialising in private equity, infrastructure and venture capital in Spain, has appointed Enrique Centelles Satrústegui as...
Advertisement
